Table 1 Patients’ characteristics at first assessment for ART eligibility
ART eligibility status | ||||||
|---|---|---|---|---|---|---|
Patients’ characteristics | Eligible | Not eligible | Total | |||
n | (%) | n | (%) | n | (%) | |
Total | 217 | (52) | 204 | (48) | 421 | (100) |
Gender | ||||||
Males | 79 | (36) | 71 | (35) | 150 | (36) |
Females | 138 | (64) | 133 | (65) | 271 | (64) |
WHO clinical stage | ||||||
1 | 38 | (18) | 109 | (53) | 147 | (35) |
2 | 64 | (29) | 67 | (33) | 131 | (31) |
3 | 81 | (37) | 28 | (14) | 109 | (26) |
4 | 34 | (16) | 0 | (0) | 34 | (8) |
Age (years) | ||||||
13-19 | 7 | (3) | 3 | (1) | 10 | (2) |
20-29 | 53 | (24) | 40 | (20) | 93 | (22) |
30-39 | 81 | (37) | 90 | (44) | 171 | (22) |
40 + | 76 | (35) | 71 | (35) | 147 | (35) |
Mean (SD) | 37.0 (11.8) | 37.0 (10.4) | 37.0 (11.1) | |||
Median [IQR] | 35.0 [29-43] | 36.0 [30-43] | 35.0 [30-43] | |||
Range | 14 – 78 | 14 – 72 | 14-78 | |||
CD4 cell counts/μL1 | ||||||
<200 | 186 | (86) | 0 | (0) | 186 | (45) |
≥200 | 30 | (14) | 202 | (100) | 232 | (56) |
Mean (SD) | 127 (155) | 519 (254) | 317 (287) | |||
Median [IQR] | 114 [37-179] | 466 [314-663] | 225 [107-466] | |||
Range | 1 – 1764 | 201 – 1298 | 1-1764 | |||